BORAM SONG: Open Payments
NPI 1063894475 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 6 payments from 5 companies in 2025. Trend: 2023 $469 · 2024 $285 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| Gilead Sciences, Inc. | 1 | $29 |
| Galderma Laboratories, L.P. | 1 | $18 |
| BioCryst US Sales Co., LLC | 1 | $14 |
Products named: DUPIXENT, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
